MARIANI, MARIANNA
 Distribuzione geografica
Continente #
NA - Nord America 472
EU - Europa 165
AS - Asia 76
SA - Sud America 19
AF - Africa 15
Totale 747
Nazione #
US - Stati Uniti d'America 470
IT - Italia 59
CN - Cina 26
UA - Ucraina 21
SG - Singapore 20
BR - Brasile 17
SE - Svezia 16
IE - Irlanda 15
RU - Federazione Russa 15
DE - Germania 12
CI - Costa d'Avorio 9
GB - Regno Unito 9
IN - India 9
DK - Danimarca 8
TR - Turchia 8
FI - Finlandia 6
MA - Marocco 6
KR - Corea 5
HK - Hong Kong 4
BE - Belgio 2
IR - Iran 2
CA - Canada 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
IQ - Iraq 1
LK - Sri Lanka 1
NO - Norvegia 1
PE - Perù 1
Totale 747
Città #
Fairfield 67
Des Moines 52
Chandler 47
Ashburn 29
Wilmington 28
Houston 26
Woodbridge 25
New York 24
Jacksonville 23
Seattle 22
Boardman 18
Dublin 15
Cambridge 14
Ann Arbor 10
Singapore 10
Abidjan 9
Marche 9
San Mateo 8
Beijing 7
Lawrence 7
Princeton 7
Redmond 7
Turin 7
Milan 5
Hong Kong 4
Mumbai 4
Pune 4
Shanghai 4
Moscow 3
Ancona 2
Brussels 2
Falconara Marittima 2
Guangzhou 2
Helsinki 2
Los Angeles 2
Prescot 2
Terlizzi 2
Venice 2
Washington 2
Wuhan 2
Wuxi 2
Acton 1
Anápolis 1
Araraquara 1
Bogotá 1
Brasília 1
Caxias do Sul 1
Centro 1
Chennai 1
Chiswick 1
Colombo 1
Dalian 1
Dallas 1
Fermo 1
Glendale 1
Gravataí 1
Hangzhou 1
Icó 1
Ipatinga 1
Kilburn 1
Kish 1
Lima 1
London 1
Manaus 1
Mariana 1
Montreal 1
Morada Nova de Minas 1
Novo Hamburgo 1
Olomouc 1
Oslo 1
Padre Paraíso 1
Pesaro 1
Philadelphia 1
Porto 1
Porto Seguro 1
Rome 1
San Benedetto del Tronto 1
San Diego 1
San José 1
Seoul 1
Southwark 1
Stockholm 1
São Lourenço 1
São Paulo 1
The Dalles 1
Tianjin 1
Tolentino 1
Torres 1
Valparaíso de Goiás 1
Zibo 1
Totale 568
Nome #
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 160
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 114
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis 104
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 89
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 83
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype 81
Screening of psychological distress in oncology and hematology department at Ospedali Riuniti Ancona 78
Mesenchymal stem cells of myelodysplastic syndromes show impaired hematopoietic support function and global DNA hypermethylation status 66
Totale 775
Categoria #
all - tutte 3.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.773


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 0 0 0 0 0 0 8
2020/2021238 0 12 4 7 47 71 28 8 23 8 18 12
2021/202274 1 11 3 3 4 4 5 5 7 12 9 10
2022/2023166 15 17 7 13 4 65 1 5 23 0 16 0
2023/202494 10 4 3 8 11 37 2 2 0 5 1 11
2024/2025111 27 15 2 2 10 4 4 0 23 7 14 3
Totale 775